Publications & Research

Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning

This review demonstrates that FDG-PET (a form of PET/CT) can detect a tumor’s response to radiation or chemotherapy within three to four weeks post-treatment, making it possible to more quickly modify therapy regimens and increase treatment effectiveness.

Click here to read the full review.

  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More